TNF Pharmaceuticals is a pharmaceutical company dedicated to the development of innovative therapeutic platforms, with a focus on an oral TNF-alpha inhibitor and Supera-CBD. The company aims to advance its legacy therapeutic platforms while maximizing shareholder value.